These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 28903781)

  • 61. Post-translational modification of lysine residues in erythrocyte α-synuclein.
    Amagai R; Yoshioka S; Otomo R; Nagano H; Hashimoto N; Sakakibara R; Tanaka T; Okado-Matsumoto A
    J Biochem; 2023 Mar; 173(3):177-184. PubMed ID: 36469357
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A new MAP-Rasagiline conjugate reduces α-synuclein inclusion formation in a cell model.
    Vale N; Alves C; Sharma V; Lázaro DF; Silva S; Gomes P; Outeiro TF
    Pharmacol Rep; 2020 Apr; 72(2):456-464. PubMed ID: 32048262
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Extracellular Vesicles for the Diagnosis of Parkinson's Disease: Systematic Review and Meta-Analysis.
    Xylaki M; Chopra A; Weber S; Bartl M; Outeiro TF; Mollenhauer B
    Mov Disord; 2023 Sep; 38(9):1585-1597. PubMed ID: 37449706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
    Filippini A; Gennarelli M; Russo I
    Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
    [TBL] [Abstract][Full Text] [Related]  

  • 65. C-terminal truncation exacerbates the aggregation and cytotoxicity of α-Synuclein: A vicious cycle in Parkinson's disease.
    Ma L; Yang C; Zhang X; Li Y; Wang S; Zheng L; Huang K
    Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3714-3725. PubMed ID: 30290273
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease.
    Shams R; Banik NL; Haque A
    Prog Mol Biol Transl Sci; 2019; 167():107-124. PubMed ID: 31601400
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia.
    Dai M; Yan L; Yu H; Chen C; Xie Y
    J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Origins and effects of extracellular alpha-synuclein: implications in Parkinson's disease.
    Lee SJ
    J Mol Neurosci; 2008; 34(1):17-22. PubMed ID: 18157654
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
    Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
    Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alpha-Synuclein Proteins Promote Pro-Inflammatory Cascades in Microglia: Stronger Effects of the A53T Mutant.
    Hoenen C; Gustin A; Birck C; Kirchmeyer M; Beaume N; Felten P; Grandbarbe L; Heuschling P; Heurtaux T
    PLoS One; 2016; 11(9):e0162717. PubMed ID: 27622765
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Propagation of Parkinson's disease by extracellular vesicle production and secretion.
    Shippey LE; Campbell SG; Hill AF; Smith DP
    Biochem Soc Trans; 2022 Oct; 50(5):1303-1314. PubMed ID: 36111783
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.
    Sanchez-Guajardo V; Febbraro F; Kirik D; Romero-Ramos M
    PLoS One; 2010 Jan; 5(1):e8784. PubMed ID: 20098715
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
    Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
    Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Calcium influx: An essential process by which α-Synuclein regulates morphology of erythrocytes.
    Yang Y; Shi M; Liu X; Zhu Q; Xu Z; Liu G; Feng T; Stewart T; Zhang J
    J Adv Res; 2024 Aug; 62():187-198. PubMed ID: 37714326
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extracellular Vesicles in the Treatment of Parkinson's Disease: A Review.
    Yang X; Ma Y; Xie H; Dong S; Rao G; Yang Z; Zhang J; Wu Q
    Curr Med Chem; 2021; 28(31):6375-6394. PubMed ID: 33441061
    [TBL] [Abstract][Full Text] [Related]  

  • 76. On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft.
    Park JY; Kim KS; Lee SB; Ryu JS; Chung KC; Choo YK; Jou I; Kim J; Park SM
    J Neurochem; 2009 Jul; 110(1):400-11. PubMed ID: 19457104
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nitrated alpha-synuclein in minor salivary gland biopsies in Parkinson's disease.
    Ma LY; Gao LY; Li X; Ma HZ; Feng T
    Neurosci Lett; 2019 Jun; 704():45-49. PubMed ID: 30946930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human serum-derived α-synuclein auto-antibodies mediate NMDA receptor-dependent degeneration of CNS neurons.
    Garg P; Würtz F; Hobbie F; Buttgereit K; Aich A; Leite K; Rehling P; Kügler S; Bähr M
    J Neuroinflammation; 2024 Feb; 21(1):62. PubMed ID: 38419079
    [TBL] [Abstract][Full Text] [Related]  

  • 79. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Potential Roles of Extracellular Vesicles as Biomarkers for Parkinson's Disease: A Systematic Review.
    Valencia J; Ferreira M; Merino-Torres JF; Marcilla A; Soriano JM
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.